Lindsay W. Brubaker
Papers
1
Total Citations
133
H-Index
1
About
Dr. Lindsay W. Brubaker is a leading gynecologic oncologist and researcher whose work focuses on optimizing perioperative care and reducing thromboembolic complications in women with gynecologic cancers. Her most impactful contribution, the landmark 2020 study "Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm," has garnered 133 citations and fundamentally challenged standard practice. This pivotal work demonstrated that apixaban, an oral anticoagulant, is a safe and effective alternative to the traditional 28-day course of injectable enoxaparin for thromboprophylaxis after gynecologic cancer surgery. By addressing the critical issues of high medication costs and poor patient adherence associated with injectable therapies, Dr. Brubaker’s research has directly improved patient quality of life and clinical outcomes. Her findings have influenced evolving guidelines and provided a more accessible, patient-friendly option for preventing life-threatening postoperative blood clots. Through this high-impact study and her ongoing clinical investigations, Dr. Brubaker continues to advance evidence-based, patient-centered care in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1